Combined Ratio (Annual)

Combined Ratio: A measure of profitability used by an insurance company to indicate how well it is performing in its daily operations. The combined ratio is calculated by taking the sum of incurred losses and expenses and then dividing them by earned premium. Calculated as: Total Operating Expenses / Net Premiums Earned

Dr. Reddy's Laboratories Ltd (RDY) Combined Ratio data is not available.

Quarterly Annual

Figures for fiscal year ending 2025-03-31

Income Statement Financials
Revenue	$3.81B
Net Income	$663.00M
Cost of Goods Sold	$1.58B
Gross Profit	$2.23B
Operating Expenses	$2.97B
Operating Income	$842.00M
Non-Operating Income/Expense	$58.00M
Pre-Tax Income	$900.00M
Normalized Pre-Tax Income	$900.00M
Income after Taxes	$671.00M
Income from Continuous Operations	$671.00M
Consolidated Net Income/Loss	$671.00M
Normalized Income after Taxes	$671.00M
EBIT	$842.00M
EBITDA	$1.04B
Weighted-Average Shares Outstanding (Basic)	832.95M
Weighted-Average Shares Outstanding (Diluted)	834.18M
Earnings per Share (EPS) (Basic)	$0.79
Earnings per Share (EPS) (Diluted)	$0.79
Balance Sheet Financials
Current Assets	$2.93B
Property, Plant, and Equipment	$1.14B
Long-Term Assets	$2.84B
Total Assets	$5.77B
Current Liabilities	$1.53B
Long-Term Debt	$92.00M
Long-Term Liabilities	$298.00M
Total Liabilities	$1.82B
Common Equity	$3.95B
Tangible Shareholders Equity	$2.67B
Shareholders Equity	$3.95B
Common Shares Outstanding	834.46M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$545.00M
Cash Flow from Investing Activities	$-682.00M
Cash Flow from Financial Activities	$222.00M
Beginning Cash	$85.00M
End Cash	$171.00M
Increase/Decrease in Cash	$86.00M
Stock-Based Compensation	$5.00M
Common Stock Dividends Paid	$-78.00M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.92
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.02
Debt to Equity Ratio	0.14
Gross Margin	58.51%
Operating Margin	22.09%
EBIT Margin	22.09%
EBITDA Margin	27.34%
Pre-Tax Profit Margin	23.62%
Profit Margin	17.40%
Free Cash Flow	$229.00M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.66
Inventory Turnover	1.90
Receiveable Turnover	3.60
Days Sales in Receivables	101.33
Return on Equity	17.00%
Return on Tangible Equity	25.08%
Return on Assets	11.63%
Return on Investments	16.61%
Book Value Per Share	$4.73
Free Cash Flow per Share	$0.27
Operating Cash Flow per Share	$0.65

Data from Zacks Investment Research, Inc.